Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$6.01 +0.28 (+4.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Orchestra BioMed Holdings (OBIO) Selling, General & Administrative (2020 - 2026)

Updated

Orchestra BioMed Holdings (OBIO) posted Selling, General & Administrative of $5.83 million for Q2 2026, down 6.9% from $6.26 million a year earlier and down 8.5% from the prior quarter.

Analysis

Orchestra BioMed Holdings (OBIO) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Orchestra BioMed Holdings was $26.59 million, up 10.4% year-over-year; for FY2025, it came in at $26.91 million, up 12.5% from FY2024.

  • Annual Selling, General & Administrative has increased for three consecutive years, with a five-year compound annual growth rate of 190.5% (FY2020 to FY2025).
  • In prior years, Orchestra BioMed Holdings' Selling, General & Administrative was $23.93 million in FY2024 (+18.1%), $20.26 million in FY2023 (+44.3%), $14.03 million in FY2022 and $274,756 in FY2021 (+111.4%).
  • The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q3 2024.
  • On a year-over-year basis, Selling, General & Administrative increased in five of the last eight quarters, with growth averaging 9.6%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2023, with growth of 80.5%; the weakest was Q3 2024, with a decline of 10.7%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $6.37 million (Q1 2026), $7.29 million (Q4 2025) and $7.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 2.32 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 4.27 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 2.16 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 633.40 Mn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 3.20 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 2.31 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 1.68 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 560.90 Mn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 1.26 Bn
10 Orchestra BioMed Holdings 352.13 Mn -49.69 Mn 63,000.00 5.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.63 Mn
Jun 30, 2026 5.83 Mn
Mar 31, 2026 6.37 Mn
Dec 31, 2025 7.29 Mn
Sep 30, 2025 7.10 Mn
Jun 30, 2025 6.26 Mn
Mar 31, 2025 6.26 Mn
Dec 31, 2024 5.90 Mn
Sep 30, 2024 5.67 Mn
Jun 30, 2024 6.47 Mn
Mar 31, 2024 5.90 Mn
Dec 31, 2023 4.19 Mn
Sep 30, 2023 6.34 Mn
Jun 30, 2023 5.32 Mn
Mar 31, 2023 4.41 Mn
Dec 31, 2022 3.34 Mn
Sep 30, 2022 5.28 Mn
Jun 30, 2022 2.95 Mn
Mar 31, 2022 2.48 Mn
Dec 31, 2021 62,045.00
API Access

Orchestra BioMed Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OBIO&period=max&api_key=YOUR_API_KEY